Cajanolactone A alleviates high-fat diet-induced MAFLD by modulating liver de novo lipogenesis, inflammatory signaling, and bile acid composition in the gut-liver axis
Fields of Study & Subjects
Liver Disease Diagnosis and Treatment
Diet
Metabolism
and Disease
Gut microbiota and health
Publication details
- Journal / source
- Biochemical Pharmacology
- Volume
- 246
- Pages
- 117717–117717
- Publication date
- 17 January 2026
- Language
- EN